Canada Research Roundup: Antibe Therapeutics, Canadian Natural Resources, Turquoise Hill Resources

Autocanada

18/10/2021 08:24

Oct 18 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Antibe Therapeutics, Canadian Natural Resources and Turquoise Hill
Resources, on Monday. 
    
    HIGHLIGHTS    
     * Antibe Therapeutics Inc  ATE.TO : Canaccord Genuity cuts to hold from speculative buy
     * Canadian Natural Resources Ltd  CNQ.TO : Credit Suisse raises target to C$59 from C$53 
     * Turquoise Hill Resources Ltd  TRQ.TO : Canaccord Genuity cuts to sell from hold
        
Following is a summary of research actions on Canadian companies reported by Reuters on Monday.
Stock entries are in alphabetical order. 

     * Abc Technologies Holdings  ABCT.TO : National Bank of Canada cuts PT to C$9 from C$9.5 
     * Antibe Therapeutics Inc  ATE.TO : Canaccord Genuity cuts to hold from speculative buy
     * Antibe Therapeutics Inc  ATE.TO : Canaccord Genuity cuts target price to C$1.20 from C$5 
     * Autocanada Inc  ACQ.TO : National Bank of Canada cuts target price to C$60 from C$64 
     * Canadian Natural Resources Ltd  CNQ.TO : Credit Suisse raises target to C$59 from C$53 
     * Enerflex Ltd  EFX.TO : National Bank of Canada raises target price to C$12.50 from C$10.50 
     * Premium Brands Holdings Corp  PBH.TO : National Bank of Canada ups PT to C$148 from C$141 
     * Spin Master Corp  TOY.TO : Scotiabank cuts target price to C$48 from C$50 
     * Stelco Holdings Inc  STLC.TO : National Bank of Canada cuts target to C$60 from C$62 
     * Turquoise Hill Resources Ltd  TRQ.TO : Canaccord Genuity cuts to sell from hold
     * Turquoise Hill Resources Ltd  TRQ.TO : Canaccord Genuity cuts target to C$14 from C$19 
     * Turquoise Hill Resources Ltd  TRQ.TO : Eight Capital cuts target price to C$16 from C$30 
     * Turquoise Hill Resources Ltd  TRQ.TO : Eight Capital cuts to sell from buy 
     * Valens Company Inc  VLNS.TO : Canaccord Genuity cuts target price to C$3.75 from C$4.25 
       

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))